U.S. Healthcare Services Stock News

Copa Holdings (NYSE:CPA) drew fresh attention after reporting a 20.5% year-over-year jump in fiscal Q1 2026 earnings per share, along with improved operating and net margins that have caught investors' interest. See our latest analysis for Copa Holdings. At a share price of $142.16, Copa Holdings has seen its 30 day share price return rise 24.08%, while the 1 year total shareholder return of 38.18% points to momentum that has been building rather than fading. If this earnings driven move has...

FinVolution Group stock triggered by valuation gap FinVolution Group (FINV) is on investor radars after trading at an indicated intrinsic discount of about 70%, with the stock last closing at US$5.19 and a market value near US$1.35b. See our latest analysis for FinVolution Group. Recent trading has been choppy, with the share price falling 5.6% over the last session but still up 8.6% over the week. The 1 year total shareholder return is down 37%, while the 3 year total shareholder return is...

FTAI Aviation (FTAI) is back in focus after Crossroads Capital LLC highlighted the stock, pointing to its shift toward a capital-light, higher-visibility model built around PMA parts and a vertically integrated engine platform. See our latest analysis for FTAI Aviation. FTAI Aviation's latest focus from Crossroads Capital and its upcoming redemption of Series C preferred shares sit against a backdrop of strong momentum, with the share price up 24.93% year to date and a very large 1 year total...

Kite Realty Group Trust (KRG) continues to draw attention after recent share price moves, with investors weighing its income profile as a real estate investment trust against its performance over the past year and past 3 months. See our latest analysis for Kite Realty Group Trust. The recent 1 month share price return of 5.12% and year to date share price return of 15.46% sit alongside a 1 year total shareholder return of 30.10%, suggesting momentum has been building over time. If KRG’s move...

PROCEPT BioRobotics recently reported two milestones in its WATER IV prostate cancer program: completing enrollment in the 280-patient randomized trial comparing Aquablation to radical prostatectomy and securing FDA IDE approval for a second randomized study against active surveillance in up to 333 patients. These long-term, randomized trials could help clarify how Aquablation stacks up against both surgery and watchful waiting on cancer control and quality-of-life outcomes over a ten-year...

Pony AI Inc. has reported its first-quarter 2026 results, with revenue rising to US$34.25 million from US$13.98 million a year earlier, while net loss widened to US$50.41 million from US$42.99 million. Alongside this rapid top-line expansion, the company raised its 2026 robotaxi fleet and revenue targets as it scales operations across more cities and international markets. We’ll now look at how Pony AI’s raised robotaxi fleet target shapes the company’s investment narrative and future growth...

Recently, JFrog Ltd. (FROG) recorded a golden cross, with its 50-day moving average moving above its 200-day moving average while analysts raised earnings estimates, reinforcing attention on the company’s technical and fundamental setup. This combination of a widely watched technical signal and improving earnings expectations offers a rare alignment of chart-based and estimate-driven optimism for JFrog. We’ll now explore how this golden cross, together with stronger earnings estimates, might...

This article explores whether Nu Holdings is attractively priced or starting to look stretched, by examining what the current share price might be implying about the stock's underlying value. After closing at US$13.05, the stock is down 0.8% over the past week and down 10.0% over the past month. Over the past year the return is 8.8%, and the 3 year return is 91.1%. Recent coverage has focused on Nu Holdings as a fast growing digital bank in Latin America, which helps explain why investors...

STERIS (STE) shares have faced pressure recently, with the stock down about 2% over the past month and about 15% over the past 3 months, drawing attention to its current valuation. See our latest analysis for STERIS. Zooming out, the recent 3 month share price decline of about 14.6% and year to date share price decline of about 13.9% contrast with a 5 year total shareholder return of 18.6%. This suggests momentum has softened despite longer term gains. If you are comparing STERIS with other...

Ituran Location and Control (NasdaqGS:ITRN) has filed a universal shelf registration, allowing the company to issue a range of securities in the future. The filing enables potential offerings of ordinary shares, debt securities, warrants, and rights, depending on future funding needs and market conditions. Ituran Location and Control operates in vehicle tracking and telematics, providing location based services and control systems. The new shelf registration adds an extra funding tool...

Earnings and Clinical Data Put Roivant in Focus Roivant Sciences (ROIV) has moved into the spotlight after reporting Phase 2b results for IMVT-1402 in difficult-to-treat rheumatoid arthritis, alongside recent fourth quarter earnings and a new shelf registration filing. See our latest analysis for Roivant Sciences. At a share price of US$29.88, Roivant has seen a 36.25% year to date share price return and a very large 1 year total shareholder return, suggesting momentum has built around the...

In the past few days, law firm Levi & Korsinsky began investigating ZoomInfo Technologies Inc. for potential federal securities law violations after the company sharply reduced its 2026 revenue and operating income guidance following earlier upbeat forecasts. The sudden guidance cut, coming so soon after optimistic full-year expectations, has raised fresh questions for investors about management communication and forecasting reliability. We’ll now explore how this new legal investigation...

Rezolve AI (RZLV) is back in focus after Enhanced Group Inc. selected the company to power Live Enhanced, a new direct to consumer digital telehealth platform built around AI driven medical concierge services. See our latest analysis for Rezolve AI. Rezolve AI's latest partnership news lands after a mixed price pattern, with a 1 day share price return of 9.02%, a 90 day share price return of 19.31% and a 3 year total shareholder return that is still down 72.88%. Recent momentum appears to be...

Earlier this week, Masco reported that it delivered solid sales growth, expanded margins and higher earnings in its latest quarterly results despite ongoing macroeconomic uncertainty, supported by its established brands, pricing power and steady professional renovation demand. At the same time, commentary around flat organic revenue over the past two years and softer projected sales growth highlighted rising competitive pressures and questions about how Masco will sustain expansion without...

Uranium Energy (NYSEAM:UEC) has appointed Bradley Williams as Vice President of Government Affairs. Williams brings executive level experience in nuclear energy policy and federal government relations. The role is focused on strengthening Uranium Energy's presence in U.S. federal policy and the domestic nuclear fuel cycle. Uranium Energy, trading around $13.55, has drawn attention with a very large 3 year return and a 1 year return of 125.5%. The stock is up 3.4% over the past week,...

Why Carter's Stock Is On Investors' Radar Carter's (CRI) stock has drawn attention after recent share price moves, with the company showing a 1.9% return over the past day and nearly 6.8% over the past week. See our latest analysis for Carter's. That short burst of interest sits on top of a longer stretch where the share price has gained 20.8% year to date and 19.6% over three months, yet the 3 year total shareholder return is down 25.7% and the 5 year total shareholder return is down 52.5%...

Investors may be wondering if Amprius Technologies stock is still priced fairly after its recent run, or if expectations have already gone too far into the future. At a last close of US$20.85, the stock has delivered 36.3% over the past week, 5.9% over the past month and 138.6% year to date, with a very large 1-year return of around 7x. Recent headlines have focused on Amprius Technologies as a high growth battery technology stock, which has drawn more attention from both institutional and...

ComEd, an Exelon (NasdaqGS:EXC) subsidiary, has surpassed US$10b in Renewable Energy Credits under contract. The milestone is recorded as of the end of 2025 and reflects activity in Illinois. The contracts relate to renewable energy growth across the state, including support for clean power projects. For you as an investor, this milestone highlights how a regulated utility within Exelon is tied into Illinois’ push for cleaner power. Renewable Energy Credits are a policy tool that helps fund...

Coupang (NYSE:CPNG) is dealing with an extensive 2025 data breach affecting over 33 million customer accounts. The company has outlined a $1.2b customer compensation program in response to the incident. Management is stressing recovery efforts, cyber security upgrades, and a $2b share buyback while addressing the fallout. Coupang is under close scrutiny after the breach, with the response shaping how customers and investors view the business. The stock trades around $16.2, with shares down...

On May 19, 2026, First Merchants Corporation announced director Gary Lehman’s retirement from the board and declared a US$0.3700 quarterly dividend payable on June 19, 2026. The simultaneous addition of former KPMG partner Paul Fultz to the board and its Audit Committee highlights a reinforced focus on financial reporting and governance oversight. We’ll now examine how the appointment of experienced audit partner Paul Fultz could influence First Merchants’ existing investment narrative and...

Wondering if AutoZone at around US$3,007 a share still offers value, or if the best entry point might have passed? This article breaks down what the current price really implies. The stock has had a rough patch recently, with the share price falling 12.5% over the past week, 15.6% over the past month, and sitting down 9.0% year to date, even though the 3 year and 5 year returns are 26.7% and 116.0% respectively. Recent headlines have focused on how AutoZone fits into the broader shift in...

Immunome, Inc. recently drew investor attention as Barclays initiated coverage with an Overweight rating and the company prepared a presentation at the Goldman Sachs 47th Annual Global Healthcare Conference, with the webcast made available via its Investor Relations site. This combination of positive analyst commentary and visibility at a high-profile healthcare conference underscores Immunome’s positioning within the increasingly active antibody-drug conjugate space. We’ll now consider how...

Vaxcyte stock snapshot after recent performance shifts Vaxcyte (PCVX) has drawn fresh attention after a mixed stretch for the stock, with a small gain over the past day but declines over the past month and past 3 months shaping recent sentiment. See our latest analysis for Vaxcyte. Recent moves leave Vaxcyte with a 7 day share price return of 7.7% but a 30 day share price return down 13.1%, while the 1 year total shareholder return of 55.7% points to momentum that has been building over a...

Wondering if AeroVironment at around US$214 per share is still a good deal, or if the easy gains are already behind it? This article focuses squarely on what the current valuation might be telling you. The stock has moved sharply in the short term, with a 23.1% gain over the last 7 days and 16.8% over the last 30 days, while the return over the last year sits at 20.4%. The 3 year and 5 year returns are 116.9% and 92.6% respectively, and year to date the stock is down 16.3%. These swings have...